7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide
C17H18N8O — CID 118124972
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide
7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide (PubChem CID 118124972) has the molecular formula C17H18N8O and a molecular weight of 350.39 g/mol. Its IUPAC name is 7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide.
Molecular Properties
| Compound Name | 7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide |
|---|---|
| PubChem CID | 118124972 |
| Molecular Formula | C17H18N8O |
| Molecular Weight | 350.39 g/mol |
| Exact Mass | 350.16 |
| IUPAC Name | 7-(2-methylpyrazol-3-yl)-N-pyrazin-2-yl-1,2,3,4-tetrahydropyrido[2,3-b][1,4]diazepine-5-carboxamide |
| SMILES | Cn1nccc1-c1ccc2c(n1)N(C(=O)Nc1cnccn1)CCCN2 |
| InChI | InChI=1S/C17H18N8O/c1-24-14(5-7-21-24)12-3-4-13-16(22-12)25(10-2-6-19-13)17(26)23-15-11-18-8-9-20-15/h3-5,7-9,11,19H,2,6,10H2,1H3,(H,20,23,26) |
| InChIKey | LHQALMDKJKVTFV-UHFFFAOYSA-N |
| XLogP | 2.13 |
| TPSA | 100.86 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 350.39 |
| LogP ≤ 5 | 2.13 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118124972 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.